214 research outputs found
All-passive pixel super-resolution of time-stretch imaging
Based on image encoding in a serial-temporal format, optical time-stretch
imaging entails a stringent requirement of state-of-the- art fast data
acquisition unit in order to preserve high image resolution at an ultrahigh
frame rate --- hampering the widespread utilities of such technology. Here, we
propose a pixel super-resolution (pixel-SR) technique tailored for time-stretch
imaging that preserves pixel resolution at a relaxed sampling rate. It
harnesses the subpixel shifts between image frames inherently introduced by
asynchronous digital sampling of the continuous time-stretch imaging process.
Precise pixel registration is thus accomplished without any active
opto-mechanical subpixel-shift control or other additional hardware. Here, we
present the experimental pixel-SR image reconstruction pipeline that restores
high-resolution time-stretch images of microparticles and biological cells
(phytoplankton) at a relaxed sampling rate (approx. 2--5 GSa/s) --- more than
four times lower than the originally required readout rate (20 GSa/s) --- is
thus effective for high-throughput label-free, morphology-based cellular
classification down to single-cell precision. Upon integration with the
high-throughput image processing technology, this pixel-SR time- stretch
imaging technique represents a cost-effective and practical solution for large
scale cell-based phenotypic screening in biomedical diagnosis and machine
vision for quality control in manufacturing.Comment: 17 pages, 8 figure
Bi-allelic variants in TSPOAP1, encoding the active zone protein RIMBP1, cause autosomal recessive dystonia
Dystonia is a debilitating hyperkinetic movement disorder, which can be transmitted as a monogenic trait. Here, we describe homozygous frameshift, nonsense and missense variants in TSPOAP1, encoding the active zone RIM-binding protein 1 (RIMBP1), as a novel genetic cause of autosomal recessive dystonia in seven subjects from three unrelated families. Subjects carrying loss-of-function variants presented with juvenile-onset progressive generalized dystonia, associated with intellectual disability and cerebellar atrophy. Conversely, subjects carrying a pathogenic missense variant (p.Gly1808Ser) presented with isolated adult-onset focal dystonia. In mice, complete loss of RIMBP1, known to reduce neurotransmission, led to motor abnormalities reminiscent of dystonia, decreased Purkinje cell dendritic arborization, and reduced numbers of cerebellar synapses. In vitro analysis of the p.Gly1808Ser variant showed larger spike-evoked calcium transients and enhanced neurotransmission, suggesting that RIMBP1-linked dystonia can be caused by either reduced or enhanced rates of spike-evoked release in relevant neural networks. Our findings establish a direct link between dysfunction of the presynaptic active zone and dystonia and highlight the critical role played by well-balanced neurotransmission in motor control and disease pathogenesis
Factors related to transmission of and infection with Schistosoma mansoni in a village in the South-eastern Region of Brazil
Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B
Visceral leishmaniasis (VL), a potentially fatal disease, is most prevalent in the Indian subcontinent,
East Africa and South America. Since the conventional antileishmanial drugs have many limitations we evaluated a
new ergosterol rich liposomal amphotericin B formulation, KALSOME™10 for its leishmanicidal efficacy, tolerability
and immunomodulatory activity. Normal healthy mice were treated with 3.5 mg/kg single and 7.5 mg/kg single and double doses ofKALSOME™10. Liver and kidney function tests were performed fourteen days after treatment. Next, normal mice were infected with Leishmania donovani amastigotes. Two months post infection they were treated with the above
mentioned doses of KALSOME™10 and sacrificed one month after treatment for estimation of parasite burden in
the liver and spleen by Limiting Dilution Assay. Leishmanial antigen stimulated splenocyte culture supernatants were collected for cytokine detection through ELISA. Flow cytometric studies were performed on normal animals treated with KALSOME™10, Amphotericin B (AmB) and AmBiosome to compare their immunomodulatory activities.
The drug was found to induce no hepato- or nephrotoxicities at the studied doses. Moreover, at all doses,
it led to significant reduction in parasite burden in two month infected BALB/c mice, with 7.5 mg/kg double dose
resulting in almost complete clearance of parasites from both liver and spleen. Interestingly, the drug at 7.5 mg/kg
double dose could almost completely inhibit the secretion of disease promoting cytokines, IL-10 and TGFβ, and
significantly elevate the levels of IFNγ and IL-12, cytokines required for control of the disease. Mice treated with KALSOME™10 showed elevated levels of IFNγ and suppressed IL-10 secretion from both CD4+ and CD8+ subsets
of T cells, as well as from culture supernatants of splenocytes, compared to that of normal, AmB and AmBisome
treated animal Treatment of infected mice with 7.5 mg/kg double dose of KALSOME™10 was safe and effective in
clearing the parasites from the sites of infection. The drug maintains the inherent immunomodulatory activities of
AmB by effectively suppressing disease promoting cytokines IL-10 and TGFβ, thereby boosting IL-12 and IFNγ levels.
This emphasizes KALSOME™10 as a promising drug alternative for lifelong protection from VL
Maternal experiences of ethnic discrimination and subsequent birth outcomes in Aotearoa New Zealand
Background
Interpersonal discrimination experience has been associated with adverse birth outcomes. Limited research has evaluated this relationship within multicultural contexts outside the United States where the nature and salience of discrimination experiences may differ. Such research is important in order to help identify protective and risk factors that may mediate the relationship between discrimination experience and adverse birth outcomes.
Methods
Evaluated the relationship between perceived discrimination, as measured in pregnancy, with birth weight and gestation length among Māori, Pacific, and Asian women from Aotearoa New Zealand (N = 1653).
Results
Thirty percent of the sample reported some type of unfair treatment that they attributed to their ethnicity. For Māori women specifically, unfair treatment at work (β = − 243 g) and in acquiring housing (β = − 146 g) were associated with lower birth weight when compared to Māori women not experiencing these types of discrimination, while an ethnically motivated physical attack (β = − 1.06 week), and unfair treatment in the workplace (β = − 0.95 week), in the criminal justice system (β = − 0.55 week), or in banking (β = − 0.73 week) were associated with significantly shorter gestation.
Conclusions
Despite a high prevalence of discrimination experience among women from all ethnic groups, discrimination experience was a strong predictor of lower birth weight and shorter gestation length among indigenous Māori women only. Additional research is needed to better understand the risk and protective factors that may moderate the relationship between discrimination experience and adverse birth outcomes among women from different ethnic groups
A programme theory for liaison mental health services in England
Background:
Mechanisms by which liaison mental health services (LMHS) may bring about improved patient and organisational outcomes are poorly understood. A small number of logic models have been developed, but they fail to capture the complexity of clinical practice.
Method:
We synthesised data from a variety of sources including a large national survey, 73 in-depth interviews with acute and liaison staff working in hospitals with different types of liaison mental health services, and relevant local, national and international literature. We generated logic models for two common performance indicators used to assess organisational outcomes for LMHS: response times in the emergency department and hospital length of stay for people with mental health problems.
Results:
We identified 8 areas of complexity that influence performance, and 6 trade-offs which drove the models in different directions depending upon the balance of the trade-off. The logic models we developed could only be captured by consideration of more than one pass through the system, the complexity in which they operated, and the trade-offs that occurred.
Conclusions:
Our findings are important for commissioners of liaison services. Reliance on simple target setting may result in services that are unbalanced and not patient-centred. Targets need to be reviewed on a regular basis, together with other data that reflect the wider impact of the service, and any external changes in the system that affect the performance of LMHS, which are beyond their control
Development of system decision support tools for behavioral trends monitoring of machinery maintenance in a competitive environment
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019
BACKGROUND:
Mental health is a public health issue for European young people, with great heterogeneity in resource allocation. Representative population-based studies are needed. The Global Burden of Disease (GBD) Study 2019 provides internationally comparable information on trends in the health status of populations and changes in the leading causes of disease burden over time.
METHODS:
Prevalence, incidence, Years Lived with Disability (YLDs) and Years of Life Lost (YLLs) from mental disorders (MDs), substance use disorders (SUDs) and self-harm were estimated for young people aged 10-24 years in 31 European countries. Rates per 100,000 population, percentage changes in 1990-2019, 95% Uncertainty Intervals (UIs), and correlations with Sociodemographic Index (SDI), were estimated.
FINDINGS:
In 2019, rates per 100,000 population were 16,983 (95% UI 12,823 – 21,630) for MDs, 3,891 (3,020 - 4,905) for SUDs, and 89·1 (63·8 - 123·1) for self-harm. In terms of disability, anxiety contributed to 647·3 (432–912·3) YLDs, while in terms of premature death, self-harm contributed to 319·6 (248·9–412·8) YLLs, per 100,000 population. Over the 30 years studied, YLDs increased in eating disorders (14·9%;9·4-20·1) and drug use disorders (16·9%;8·9-26·3), and decreased in idiopathic developmental intellectual disability (–29·1%;23·8-38·5). YLLs decreased in self-harm (–27·9%;38·3-18·7). Variations were found by sex, age-group and country. The burden of SUDs and self-harm was higher in countries with lower SDI, MDs were associated with SUDs.
INTERPRETATION:
Mental health conditions represent an important burden among young people living in Europe. National policies should strengthen mental health, with a specific focus on young people.
FUNDING:
The Bill and Melinda Gates Foundatio
A geometric method for computing ocular kinematics and classifying gaze events using monocular remote eye tracking in a robotic environment
- …